High-tech biotechnologies in clinical laboratory diagnostics

Capa


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

This review presents an analysis of the current literature on the achievements in the development of the latest high-tech biomedical technologies and the prospects for their implementation in the practice of clinical diagnostic laboratories. The publications were searched in the MEDLINE, PubMed, Scopus, Cochrane Library and Google Scholar databases. The advent of high-tech research methods has revolutionized biomedical research. Many of the most promising technologies of personalized medicine are combined within the framework of omix technologies: genomics, transcriptomics, proteomics, metabolomics, lipidomics, etc. The main methods used in clinical diagnostic laboratories for the diagnosis of circulating biomarkers of various diseases are considered. The introduction of high-tech technologies in the activities of clinical diagnostic laboratories will change the approach to medical diagnostics, making it more accurate, faster and personalized. These technologies represent a synthesis of scientific discoveries, engineering solutions and high standards of analytical chemistry. They open up new opportunities for doctors and researchers, offering innovative approaches to the study of biological processes, which leads to an understanding of the molecular and cellular foundations of pathology.

Texto integral

Acesso é fechado

Sobre autores

Galina Yarovaya

Russian Medical Academy of Continuous Professional Education

Autor responsável pela correspondência
Email: galina.yarovaya.31@gmail.com
ORCID ID: 0009-0004-1761-1518

Dr. Sci. (Biology), Professor

Rússia, Moscow

Victoria Metelskaya

Russian Medical Academy of Continuous Professional Education; National Medical Research Center for Therapy and Preventive Medicine

Email: vmetelskaya@gnicpm.ru
ORCID ID: 0000-0001-8665-9129
Código SPIN: 4547-5317

Dr. Sci. (Biology), Professor

Rússia, Moscow; Moscow

Bibliografia

  1. Uhlén M, Karlsson MJ, Hober A, et al. The human secretome. Sci Signal. 2019;12(609):eaaz0274. doi: 10.1126/scisignal.aaz0274
  2. Suhre K, McCarthy MI, Schwenk JM. Genetics meets proteomics: perspectives for large population-based studies. Nat Rev Genet. 2021;22:19–37. doi: 10.1038/s41576-020-0268-2
  3. Ridker PM. Proteomics for the prediction and prevention of atherosclerotic disease. Eur Heart J. 2022;43(16):1578–1581. doi: 10.1093/eurheartj/ehac036
  4. Nurk S, Koren S, Rhie A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44–53. doi: 10.1126/science.abj6987
  5. Green ED, Gunter C, Biesecker LG, et al. Strategic vision for improving human health at The Forefront of Genomics. Nature. 2020;586:683–692. doi: 10.1038/s41586-020-2817-4
  6. Manolio TA, Rowley R, Williams MS, et al. Opportunities, resources, and techniques for implementing genomics in clinical care. The Lancet. 2019;394(10197):511–520. doi: 10.1016/S0140-6736(19)31140-7
  7. Mullis KB. The Unusual Origin of the Polymerase Chain Reaction. Sci Am. 1990;262(4):56–61. doi: 10.1038/scientificamerican0490-56
  8. Markoulatos P, Siafakas N, Moncany M. Multiplex polymerase chain reaction: A practical approach. J. Clin. Lab. Anal. 2002;16:47–51. doi: 10.1002/jcla.2058
  9. Dar MA, Arafah A, Bhat KA, et al. Multiomics technologies: role in disease biomarker discoveries and therapeutics. Briefings in Functional Genomics. 2023;22(2):76–96. doi: 10.1093/bfgp/elac017
  10. Cong Y, Endo T. A Quadruple Revolution: Deciphering Biological Complexity with Artificial Intelligence, Multiomics, Precision Medicine, and Planetary Health. OMICS: A Journal of Integrative Biology. 2024;28(6):257–260. doi: 10.1089/omi.2024.0110
  11. Kruglova NA, Filatov AV. RNA-SEQ in immunology research. Immunologiya. 2017;38(2):112–117. doi: 10.18821/0206-4952-2017-38-2-112-117
  12. Reuther J, Roy A, Monzon FA. Transcriptome Sequencing (RNA - Seq). Netto G, Kaul K, editors. Genomic Applications in Pathology. Springer, Cham. doi: 10.1007/978-3-319-96830-8_4
  13. Weber JA, Baxter DH, Zhang S, et al. The MicroRNA Spectrum in 12 Body Fluids. Clinical Chemistry. 2010;56(11):1733–1741. doi: 10.1373/clinchem.2010.147405
  14. Solayman MHM, Langaee T, Patel A, et al. Identification of Suitable Endogenous Normalizers for qRT-PCR Analysis of Plasma microRNA Expression in Essential Hypertension. Mol Biotechnol. 2016;58:179–187. doi: 10.1007/s12033-015-9912-z
  15. Mironova OI, Berdysheva MV, Elfimova EM. MicroRNA: a clinician’s view of the state of the problem. Part 2. MicroRNA as a biomarker. Eurasian Heart Journal. 2023;(2):64–71. doi: 10.38109/2225-1685-2023-2-64-71
  16. Lam MPY, Venkatraman V, Xing Y, et al. Data-Driven Approach to Determine Popular Proteins for Targeted Proteomics Translation of Six Organ Systems. Journal of Proteome Research. 2016;15(11):4126–34. doi: 10.1021/acs.jproteome.6b00095
  17. Archakov A, Aseev A, Bykov V, et al. Gene-centric view on the human proteome project: the example of the Russian roadmap for chromosome 18. Proteomics. 2011;11(10):1853–1856. doi: 10.1002/pmic.201000540
  18. Adhikari S, Nice EC, Deutsch EW, et al. A high-stringency blueprint of the human proteome. Nat Commun. 2020;11:5301. doi: 10.1038/s41467-020-19045-9
  19. Liotta LA, Kohn EC, Petricoin EF. Clinical Proteomics: Personalized Molecular Medicine. JAMA. 2001;286(18):2211–2214. doi: 10.1001/jama.286.18.2211
  20. Clish CB. Metabolomics: an emerging but powerful tool for precision medicine. Cold Spring Harb Mol Case Stud. 2015;1(1):a000588. doi: 10.1101/mcs.a000588
  21. Pietzner M, Wheeler E, Carrasco-Zanini J, et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat Commun. 2021;12(1):6822. doi: 10.1038/s41467-021-27164-0
  22. Ryazantsev DYu, Voronina DV, Zavriev SK. Immuno-PCR: Achievements and Perspectives. Biochemistry (Moscow). 2016;81(13):1754–1770. doi: 10.1134/S0006297916130113
  23. Gong H, Holcomb I, Ooi A, et al. Simple Method To Prepare Oligonucleotide-Conjugated Antibodies and Its Application in Multiplex Protein Detection in Single Cells. Bioconjugate Chem. 2016;27(1):217–225. doi: 10.1021/acs.bioconjchem.5b00613
  24. Cui M, Cheng C, Zhang L. High-throughput proteomics: a methodological mini-review. Lab Invest. 2022;102(11):1170–1181. doi: 10.1038/s41374-022-00830-7
  25. Metelskaya VA. Serum proteomic analysis: role in the search for biomarkers of atherosclerosis. Russian Journal of Preventive Medicine. 2022;25(12):135–143. doi: 10.17116/profmed202225121135
  26. Omenn GS, Lane L, Overall CM, et al. The 2023 Report on the Proteome from the HUPO Human Proteome Project. J Proteome Res. 2024;23(2):532–549. doi: 10.1021/acs.jproteome.3c00591
  27. Wang BH, Reisman S, Bailey M, et al. Peptidomic profiles of post myocardial infarction rats affinity depleted plasma using matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) mass spectrometry. Clin Transl Med. 2012;1(1):11. doi. 10.1186/2001-1326-1-11
  28. Wilhelm M, Schlegl J, Hahne H, et al. Mass-spectrometry-based draft of the human proteome. Nature. 2014;509:582–587. doi: 10.1038/nature13319
  29. Gupta S, Manubhai KP, Kulkarni V, Srivastava S. An overview of innovations and industrial solutions in Protein Microarray Technology. Proteomics. 2016;16(8):1297–1308. doi: 10.1002/pmic.201500429
  30. Gryadunov D, Shaskolsky B, Nasedkina T, et al. The EIMB Hydrogel Microarray Technology: Thirty Years Later. Acta Naturae. 2018;10(4):4–18. (In Russ.) EDN: SVXDEU
  31. Krassowski M, Das V, Sahu SK, Misra BB. State of the Field in Multi-Omics Research: From Computational Needs to Data Mining and Sharing. Front Genet. 2020;1:610798. doi: 10.3389/fgene.2020.610798
  32. Kozlakidis Z, Seiler C, Simeon-Dubach D. ISBER Best Practices Fourth Edition: A Success Story. Biopreserv Biobank. 2018;16(3):242–243. doi: 10.1089/bio.2018.29040.zjk
  33. Meshkov AN, Glotov AS, Anisimov SV, editors. Biobanking. National Guide. Triumph Publishing House; 2022. (In Russ.)

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Yarovaya G.A., Metelskaya V.A., 2025

Creative Commons License
Este artigo é disponível sob a Licença Creative Commons Atribuição–NãoComercial–SemDerivações 4.0 Internacional.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС 77 - 86785 от 05.02.2024 (ранее — ПИ № ФС 77 - 59057 от 22.08.2014).